Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Doxorubicin plus dacarbazine, doxorubicin plus ifosfamide, or doxorubicin alone as a first‐line treatment for advanced leiomyosarcoma: A propensity score matching analysis from the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma GroupCancer, 2020-06, Vol.126 (11), p.2637-2647 [Peer Reviewed Journal]2020 American Cancer Society ;2020 American Cancer Society. ;ISSN: 0008-543X ;EISSN: 1097-0142 ;DOI: 10.1002/cncr.32795 ;PMID: 32129883Digital Resources/Online E-Resources |
|
2 |
Material Type: Article
|
Pulmonary Pathology of Early-Phase 2019 Novel Coronavirus (COVID-19) Pneumonia in Two Patients With Lung CancerJournal of thoracic oncology, 2020-05, Vol.15 (5), p.700-704 [Peer Reviewed Journal]2020 International Association for the Study of Lung Cancer ;Copyright © 2020 by the International Association for the Study of Lung Cancer ;Copyright © 2020 International Association for the Study of Lung Cancer. Published by Elsevier Inc. All rights reserved. ;2020 International Association for the Study of Lung Cancer. Published by Elsevier Inc. All rights reserved. 2020 International Association for the Study of Lung Cancer ;ISSN: 1556-0864 ;EISSN: 1556-1380 ;DOI: 10.1016/j.jtho.2020.02.010 ;PMID: 32114094Full text available |
|
3 |
Material Type: Article
|
Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trialThe lancet oncology, 2020-04, Vol.21 (4), p.508-518 [Peer Reviewed Journal]2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Elsevier Ltd ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(20)30074-7 ;PMID: 32135080Full text available |
|
4 |
Material Type: Article
|
Pembrolizumab in Patients With Microsatellite Instability-High Advanced Endometrial Cancer: Results From the KEYNOTE-158 StudyJournal of clinical oncology, 2022-03, Vol.40 (7), p.752-761 [Peer Reviewed Journal]2022 by American Society of Clinical Oncology 2022 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.21.01874 ;PMID: 34990208Full text available |
|
5 |
Material Type: Article
|
Standard-of-Care Axicabtagene Ciloleucel for Relapsed or Refractory Large B-Cell Lymphoma: Results From the US Lymphoma CAR T ConsortiumJournal of clinical oncology, 2020-09, Vol.38 (27), p.3119-3128 [Peer Reviewed Journal]2020 by American Society of Clinical Oncology 2020 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.19.02104 ;PMID: 32401634Full text available |
|
6 |
Material Type: Article
|
Long-Term Outcomes and Responses to Retreatment in Patients With Melanoma Treated With PD-1 BlockadeJournal of clinical oncology, 2020-05, Vol.38 (15), p.1655-1663 [Peer Reviewed Journal]2020 by American Society of Clinical Oncology 2020 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.19.01464 ;PMID: 32053428Full text available |
|
7 |
Material Type: Article
|
Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort studyThe Lancet Oncology, 2020-07, Vol.21 (7), p.904-913 [Peer Reviewed Journal]2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020. Elsevier Ltd ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(20)30310-7 ;PMID: 32479787Digital Resources/Online E-Resources |
|
8 |
Material Type: Article
|
Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case seriesAnnals of oncology, 2018-05, Vol.29 (5), p.1180-1188 [Peer Reviewed Journal]2018 THE AUTHORS ;The Author(s) 2018. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com. 2018 ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdy058 ;PMID: 29432521Full text available |
|
9 |
Material Type: Article
|
Assessment of a Watch-and-Wait Strategy for Rectal Cancer in Patients With a Complete Response After Neoadjuvant TherapyJAMA oncology, 2019-04, Vol.5 (4), p.e185896 [Peer Reviewed Journal]EISSN: 2374-2445 ;DOI: 10.1001/jamaoncol.2018.5896 ;PMID: 30629084Digital Resources/Online E-Resources |
|
10 |
Material Type: Article
|
Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance studyThe lancet oncology, 2018-12, Vol.19 (12), p.1579-1589 [Peer Reviewed Journal]2018 Elsevier Ltd ;Copyright © 2018 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Dec 2018 ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(18)30608-9 ;PMID: 30442497Full text available |
|
11 |
Material Type: Article
|
Analysis of Margin Classification Systems for Assessing the Risk of Local Recurrence After Soft Tissue Sarcoma ResectionJournal of clinical oncology, 2018-03, Vol.36 (7), p.704-709 [Peer Reviewed Journal]ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2017.74.6941 ;PMID: 29346043Full text available |
|
12 |
Material Type: Article
|
Ablative Radiotherapy Doses Lead to a Substantial Prolongation of Survival in Patients With Inoperable Intrahepatic Cholangiocarcinoma: A Retrospective Dose Response AnalysisJournal of clinical oncology, 2016-01, Vol.34 (3), p.219-226 [Peer Reviewed Journal]2015 by American Society of Clinical Oncology. ;2015 by American Society of Clinical Oncology 2015 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2015.61.3778 ;PMID: 26503201Full text available |
|
13 |
Material Type: Article
|
Tumor mutational burden is predictive of response to immune checkpoint inhibitors in MSI-high metastatic colorectal cancerAnnals of oncology, 2019-07, Vol.30 (7), p.1096-1103 [Peer Reviewed Journal]2019 THE AUTHORS ;The Author(s) 2019. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com. 2019 ;The Author(s) 2019. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com. ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdz134 ;PMID: 31038663Full text available |
|
14 |
Material Type: Article
|
COVID-19 in patients with lung cancerAnnals of oncology, 2020-10, Vol.31 (10), p.1386-1396 [Peer Reviewed Journal]2020 European Society for Medical Oncology ;Copyright © 2020 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved. ;2020 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved. 2020 European Society for Medical Oncology ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1016/j.annonc.2020.06.007 ;PMID: 32561401Full text available |
|
15 |
Material Type: Article
|
Outcomes After Stereotactic Body Radiotherapy or Radiofrequency Ablation for Hepatocellular CarcinomaJournal of clinical oncology, 2016-02, Vol.34 (5), p.452-459 [Peer Reviewed Journal]2015 by American Society of Clinical Oncology. ;2015 by American Society of Clinical Oncology 2015 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.2015.61.4925 ;PMID: 26628466Full text available |
|
16 |
Material Type: Article
|
Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registryAnnals of oncology, 2019-08, Vol.30 (8), p.1321-1328 [Peer Reviewed Journal]2019 THE AUTHORS ;The Author(s) 2019. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com. 2019 ;The Author(s) 2019. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com. ;Distributed under a Creative Commons Attribution 4.0 International License ;2019 THE AUTHORS 2019 ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdz167 ;PMID: 31125062Full text available |
|
17 |
Material Type: Article
|
Yttrium-90 Radioembolization for the Treatment of Solitary, Unresectable HCC: The LEGACY StudyHepatology (Baltimore, Md.), 2021-11, Vol.74 (5), p.2342 [Peer Reviewed Journal]2021 The Authors. Hepatology published by Wiley Periodicals LLC on behalf of American Association for the Study of Liver Diseases. ;EISSN: 1527-3350 ;DOI: 10.1002/hep.31819 ;PMID: 33739462Digital Resources/Online E-Resources |
|
18 |
Material Type: Article
|
Propensity Score Analysis of Radical Cystectomy Versus Bladder-Sparing Trimodal Therapy in the Setting of a Multidisciplinary Bladder Cancer ClinicJournal of clinical oncology, 2017-07, Vol.35 (20), p.2299-2305 [Peer Reviewed Journal]ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.2016.69.2327 ;PMID: 28410011Full text available |
|
19 |
Material Type: Article
|
Recurrence Rates in Patients With Cervical Cancer Treated With Abdominal Versus Minimally Invasive Radical Hysterectomy: A Multi-Institutional Retrospective Review StudyJournal of clinical oncology, 2020-04, Vol.38 (10), p.1030-1040 [Peer Reviewed Journal]ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.19.03012 ;PMID: 32031867Full text available |
|
20 |
Material Type: Article
|
Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199Journal of clinical oncology, 2014-09, Vol.32 (27), p.2959-2966 [Peer Reviewed Journal]2014 by American Society of Clinical Oncology 2014 ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.2013.55.0491 ;PMID: 25071121Full text available |